Stocks-ADVM-Adverum Biotechnologies Inc

ADVM Adverum Biotechnologies Inc

0 0 (0%)
Market ClosedDelayed Prices By NASDAQ, in USD
Trade
Trade

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2022: Adverum Biotechnologies Inc's revenues decreased by 100.00% and amounted to 0.00. Net income decreased by 6.18% to -154.54M. Net assets decreased by 42.59% to 181.52M and EPS decreased from -1.48 to -1.56.
ADVM's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
-268.97%
Net Profit Margin
-6,933.73%
Operating Margin
-3,660.36%
Return On Investment
-37.07%